Akari Therapeutics PLC Cash Flow Quality Index

Latest as of March 2023: -4.88x

Akari Therapeutics PLC cash flow quality index. Akari Therapeutics PLC (AKTX) has a Cash Flow Quality Index of -4.88x as of March 2023. Operating cash flow of $-4.88 Million is below net income of $1.00 Million, suggesting accrual-heavy earnings not yet converted to cash. See AKTX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-4.88x

Operating CF / Net Income

Operating Cash Flow

$-4.88 Million

USD

Net Income

$1.00 Million

USD

Data as of

Mar 2023

Most recent filing

Akari Therapeutics PLC Cash Flow Quality Index by Year (None–None)

Akari Therapeutics PLC cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Akari Therapeutics PLC. For the full cash flow conversion analysis, see AKTX cash generation efficiency.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.